Similar articles

• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.

  Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP. Angiolillo DJ, et al. Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722. Circulation. 2018. PMID: 30571525 Review.
• Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.

  Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP. Angiolillo DJ, et al. Circ Cardiovasc Interv. 2016 Nov;9(11):e004395. doi: 10.1161/CIRCINTERVENTIONS.116.004395. Circ Cardiovasc Interv. 2016. PMID: 27803042 Review.
• Switching Oral Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

  Franchi F, Rollini F. Franchi F, et al. JACC Cardiovasc Interv. 2019 Dec 9;12(23):2342-2345. doi: 10.1016/j.jcin.2019.10.017. JACC Cardiovasc Interv. 2019. PMID: 31806215 No abstract available.
• Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies.

  Bainey KR, Morais J, Zeymer U, Welsh RC. Bainey KR, et al. Atherosclerosis. 2019 Oct;289:118-125. doi: 10.1016/j.atherosclerosis.2019.08.021. Epub 2019 Aug 30. Atherosclerosis. 2019. PMID: 31494384 Review.
• Antithromboembolic Strategies for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

  Ather A, Laliberte B, Reed BN, Schenk A, Watson K, Devabhakthuni S, See VY. Ather A, et al. Am J Cardiovasc Drugs. 2018 Dec;18(6):441-455. doi: 10.1007/s40256-018-0287-y. Am J Cardiovasc Drugs. 2018. PMID: 29915905 Review.